These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 1789712

  • 1. Validation of spontaneous morphine withdrawal symptoms in rats.
    van der Laan JW, van 't Land CJ, Loeber JG, de Groot G.
    Arch Int Pharmacodyn Ther; 1991; 311():32-45. PubMed ID: 1789712
    [Abstract] [Full Text] [Related]

  • 2. [A study on drug dependence using fast acting drugs].
    Yanaura S, Tagashire E, Izumi T.
    Nihon Yakurigaku Zasshi; 1975 May; 71(4):329-37. PubMed ID: 1237448
    [Abstract] [Full Text] [Related]

  • 3. Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice.
    Li T, Hou Y, Cao W, Yan CX, Chen T, Li SB.
    Neurosci Lett; 2010 Jan 14; 468(3):348-52. PubMed ID: 19922770
    [Abstract] [Full Text] [Related]

  • 4. Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats.
    Dzoljic ED, Kaplan CD, Dzoljic MR.
    Arch Int Pharmacodyn Ther; 1988 Jan 14; 294():64-70. PubMed ID: 3233054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Afobazole decreases severity of morphine withdrawal syndrome: experimental evidence].
    Konstantinopol'skiĭ MA, Cherniakova IV.
    Eksp Klin Farmakol; 2011 Jan 14; 74(10):12-6. PubMed ID: 22238980
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS, Sparber SB.
    J Pharmacol Exp Ther; 1986 Jan 14; 236(1):157-65. PubMed ID: 3001281
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Neuropharmacological studies on drug dependence (I). Effects due to the difference in strain, sex and drug administration time on physical dependence development and characteristics of withdrawal signs in CNS-affecting drug dependent rats (author's transl)].
    Yoshimura K, Yamamoto K.
    Nihon Yakurigaku Zasshi; 1979 Nov 14; 75(8):805-28. PubMed ID: 575638
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S, Göktalay G, Millington WR.
    J Pharmacol Exp Ther; 2005 Nov 14; 315(2):949-58. PubMed ID: 16079299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.